1. Home
  2. OTLK vs MESA Comparison

OTLK vs MESA Comparison

Compare OTLK & MESA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • MESA
  • Stock Information
  • Founded
  • OTLK 2010
  • MESA 1982
  • Country
  • OTLK United States
  • MESA United States
  • Employees
  • OTLK N/A
  • MESA N/A
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • MESA Air Freight/Delivery Services
  • Sector
  • OTLK Health Care
  • MESA Consumer Discretionary
  • Exchange
  • OTLK Nasdaq
  • MESA Nasdaq
  • Market Cap
  • OTLK 56.3M
  • MESA 46.7M
  • IPO Year
  • OTLK 2016
  • MESA 2018
  • Fundamental
  • Price
  • OTLK $1.48
  • MESA $0.90
  • Analyst Decision
  • OTLK Strong Buy
  • MESA
  • Analyst Count
  • OTLK 5
  • MESA 0
  • Target Price
  • OTLK $10.20
  • MESA N/A
  • AVG Volume (30 Days)
  • OTLK 479.6K
  • MESA 179.9K
  • Earning Date
  • OTLK 02-14-2025
  • MESA 03-18-2025
  • Dividend Yield
  • OTLK N/A
  • MESA N/A
  • EPS Growth
  • OTLK N/A
  • MESA N/A
  • EPS
  • OTLK N/A
  • MESA N/A
  • Revenue
  • OTLK N/A
  • MESA $475,518,000.00
  • Revenue This Year
  • OTLK N/A
  • MESA $15.09
  • Revenue Next Year
  • OTLK $288.46
  • MESA $16.19
  • P/E Ratio
  • OTLK N/A
  • MESA N/A
  • Revenue Growth
  • OTLK N/A
  • MESA N/A
  • 52 Week Low
  • OTLK $0.87
  • MESA $0.75
  • 52 Week High
  • OTLK $12.85
  • MESA $1.89
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 40.05
  • MESA 31.85
  • Support Level
  • OTLK $1.38
  • MESA $0.88
  • Resistance Level
  • OTLK $1.51
  • MESA $1.30
  • Average True Range (ATR)
  • OTLK 0.12
  • MESA 0.07
  • MACD
  • OTLK 0.02
  • MESA -0.02
  • Stochastic Oscillator
  • OTLK 38.86
  • MESA 13.51

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

About MESA Mesa Air Group Inc.

Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.

Share on Social Networks: